| |
PUBLISHER: |
|
 |
 |
 |
View In Browser |
 |
Download Standalone |
To view the Standalone version, you require the installation of the small file size DNL Reader. To get the DNL Reader, click the "Get DNL Reader" button:
 |
|
|
|
|
Random House |
|
EBOOK DESCRIPTION: |
|
If you believe that the latest blockbuster medication is worth a premium price over your generic brand, or that doctors have access to all the information they need about a drug’s safety and effectiveness each time they write a prescription, Dr. Jerry Avorn has some sobering news. Drawing on more than twenty-five years of patient care, teaching, and research at Harvard Medical School, he shares his firsthand experience of the wide gap in our knowledge of the effectiveness of one medication as compared to another. In Powerful Medicines, he reminds us that every pill we take represents a delicate compromise between the promise of healing, the risk of side effects, and an increasingly daunting price. The stakes on each front grow higher every year as new drugs with impressive power, worrisome side effects, and troubling costs are introduced.
This is a comprehensive behind-the-scenes look at issues that affect everyone: our shortage of data comparing the worth of similar drugs for the same condition; alarming lapses in the detection of lethal side effects; the underuse of life-saving medications; lavish marketing campaigns that influence what doctors prescribe; and the resulting upward spiral of costs that places vital drugs beyond the reach of many Americans.
In this engagingly written book, Dr. Avorn asks questions that will interest every consumer: How can a product judged safe by the Food and Drug Administration turn out to have unexpectedly lethal side effects? Why has the nation’s drug bill been growing at nearly 20 percent per year? How can physicians and patients pick the best medication in its class? How do doctors actually make their prescribing decisions, and why do those decisions sometimes go wrong? Why do so many Americans suffer preventable illnesses and deaths that proper drug use could have averted? How can the nation gain control over its escalating drug budget without resorting to rationing or draconian governmental controls? |
|
PUBLISHER'S WEB SITE: |
|
Random House
|
|
Random House, Inc. is the world's largest English-language general trade book publisher. It is a division of Bertelsmann AG, one of the foremost media companies in the world.
Random House, Inc. assumed its current form with its acquisition by Bertelsmann in 1998, which brought together the imprints of the former Random House, Inc. with those of the former Bantam Doubleday Dell. Random House, Inc.'s publishing groups include, the Bantam Dell Publishing Group, the Crown Publishing Group, the Doubleday Broadway Publishing Group, the Knopf Publishing Group, the Random House Audio Publishing Group, Random House Children's Books, the Random House Diversified Publishing Group, the Random House Information Group, the Random House Publishing Group, and Random House Ventures.
Together, these groups and their imprints publish fiction and nonfiction, both original and reprints, by some of the foremost and most popular writers of our time. They appear in a full range of formats - including hardcover, trade paperback, mass market paperback, audio, electronic, and digital, for the widest possible readership from adults to young adults and children.
The reach of Random House, Inc. is global, with subsidiaries and affiliated companies in Canada, the United Kingdom, Australia, New Zealand, and South Africa. Through Random House International, the books published by the imprints of Random House, Inc. are sold in virtually every country in the world.
Random House has long been committed to publishing the best literature by writers both in the United States and abroad. In addition to their commercial success, books published by Random House, Inc. have won more major awards than those published by any other company - including the Nobel Prize, the Pulitzer Prize, the National Book Award, and the National Book Critics Circle Award. |
|
|
|
AUTHOR: |
|
Jerry Avorn, M.D., Avorn, Jerry Md |
|
|
|
RELATED: |
|
jerry avorn m.d. avorn jerry md knopf doubleday publishing group the benefits risks and costs of prescription drugs medical / administration random house |
|
|
|
|
|
